Silver Sponsors
Deciphera Pharmaceuticals AG
Deciphera is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer. Leveraging our proprietary switch-control kinase inhibitor platform and expertise in kinase biology, we are advancing multiple product candidates from our platform in clinical studies.
Servier
Servier is a global pharmaceutical group governed by a Foundation, with a strong international presence in 150 countries. Servier aims to become a focused and innovative player in oncology as the Group has placed it among its priorities, allocating over 50% of R&D investment to this field, balanced between monoclonal antibodies and targeted small molecules.
Bronze Sponsor
Boehringer Ingelheim
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term, sustainable perspective.
Premium Educational Grant Sponsor
Bayer
Bayer is committed to delivering SCIENCE FOR A BETTER LIFE by advancing a portfolio of innovative treatments. The oncology franchise includes both marketed products and clinical development compounds, which reflect the company’s approach to research: prioritizing targets and pathways with the potential to impact the way that cancer is treated.